Business Insider8d
Cytokinetics provided milestones expected in 2025
Omecamtiv mecarbil: Continue patient enrollment in COMET-HF, a confirmatory Phase 3 clinical of omecamtiv mecarbil in patients with symptomatic heart failure with severely reduced ejection ...
Business Insider11d
Aficamten Poised for Best-in-Class Status in oHCM Treatment with Anticipated Phase 3 Data and Promising Trial Results
One key element is the anticipated Phase 3 MAPLE-HCM data, expected in the first half of 2025, which is seen as a critical catalyst for aficamten’s expanded use. The drug aims to become the ...
IEEE7d
CFO-CR: Carrier Frequency Offset Methodology for High-Rate Common Randomness Generation
Abstract: Common Randomness (CR) provides sequences of random variables at two physically separated locations. Ideally, the random variables at the two locations should be identical, i.e., have low ...
Odisha TV19d
'One Nation One Subscription' Phase-1 begins: Rs 6000 cr allocated, 1.8 cr students to benefit
The Phase-1 of the 'One Nation One Subscription' (ONOS) scheme has come into effect from today. The Centre has allocated Rs 6,000 crore for smooth implementation till to 31st December 2027. The ONOS ...
Cancer Research21d
Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas
1Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 2The University of Texas MD Anderson Cancer Center, UTHealth Houston Graduate ...